You Searched For "Bharat Biotech Chairman" and got 20 results
Sort By:
Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD
"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…
PTI
Bharat Biotech working on TB vaccine, to ink pact with a firm for technology
"Our honourable Prime Minister (Narendra Modi) has got an agenda of 2025 for the eradication of tub…
PTI
Study shows booster dose of Covaxin has neutralising effect on Omicron, Delta variants, says Bharat Biotech
The study conducted at Emory University demonstrated that subjects who received a booster dose o…
PTI
KTR congratulates Bharat Biotech on Covaxin approval
Hyderabad, Jan 3 (IANS) Telangana Minister for Industry and Information Technology K.T. Rama Rao on…
Bharat Biotech to make antigen for first-ever anti-malaria vaccine
The first dose of the vaccine has reached more than 500,000 children since the pilots we…
Bharat Biotech sees rivals’ conspiracy in all the criticism for the approval for Covaxin
Bharat Biotech chairman and managing director, Krishna Ella, believes that the gossip-mongering …
OPINION: No matter what Bharat Biotech says, Covaxin is just not ready for approvals
Benefits like how effective the vaccine is in preventing disease, and risks such as high morta…
Bharat Biotech inks deal to supply Covaxin to Brazil
Hyderabad, Jan 12 (IANS) Bharat Biotech on Tuesday announced it has signed an agreement with Precis…
Bharat Biotech gets permission to manufacture 'Covaxin' for sale
New Delhi, Jan 3 (IANS) The Central Licensing Authority on Saturday granted permission to Hyderabad…
Covaxin shows 77.8% effectiveness against symptomatic COVID-19 cases in phase-3 trials
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptoma…
PTI
US drug regulator rejects emergency use authorisation for India's Covaxin
"The company will no longer pursue an Emergency Use Authorization (EUA) for Covaxin. The FDA p…
PTI
Covaxin generated excellent safety data, says Bharat Biotech
Hyderabad, Jan 3 (IANS) Amid the criticism of the Drug Controller General of India (DCGI) for grant…
Bharat Biotech's BSL-3 aims to produce 700 million doses of Covaxin per annum
Biotechnology major Bharat Biotechs BSL-3 (Biosafety Level-3) facilities will play a pivotal role i…
Covaxin priced at ₹600 and ₹1200 for state and private hospitals respectively
The company also revealed that Covaxin’s export prices have been set at $15-$20. In a stateme…
PTI
Don't deserve this backlash, says Covaxin maker Bharat Biotech
Hyderabad, Jan 4 (IANS) Bharat Biotech Chairman Krishna Ella said on Monday that the company does n…
Giant leap for innovation: Bharat Biotech after DCGI approval to Covaxin
Hyderabad, Jan 3 (IANS) Bharat Biotech on Sunday said the approval for emergency use of its Covid-1…
Covaxin can deal with new Covid strains too: Bharat Biotech
Hyderabad, Dec 30 (IANS) Bharat Biotech said on Tuesday that its vaccine candidate, Covaxin, will b…
Bharat Biotech to start Phase-1 trials for its second COVID-19 vaccine in Feb-March
Besides Covaxin, Bharat Biotech has been actively working on developing another vaccine, for whi…
PTI
Bharat Biotech gets permission to manufacture covid 19 vaccine 'covaxin' for sale
New Delhi, Jan 3 (IANS) The Central Licensing Authority on Saturday granted permission to Hyderabad…
Bharat Biotech partners with Washington varsity for intranasal COVID-19 vaccine
The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA,…